IDefine is committed to identifying life-changing treatments & cures for those with rare genetic disorders like Kleefstra Syndrome (KS), while building community for families. Our initial concentration is centered around KS, a rare genetic disorder caused by a mutation or deletion of the EHMT1 gene.
In consultation with our Scientific Advisory Board, we are pursuing the most promising avenues for drug development, and will "go where the science takes us". A range of approaches are being reviewed, including small-molecule drug repurposing, small molecule drug development, oligonucleotide-based therapies, and gene therapies.
Company Details
- Employees
- 9
- Founded
- -
- Address
- Atlanta, Ga, Us
- Industry
- Non-Profit Organization Management
- Website
- idefine.org
- Keywords
- Kleefstra Syndrome, Drug Development, Intellectual Disability, Charity, Fundraising, Rare Disease Research, Non-Profit.
- HQ
- Atlanta, GA
Idefine-The Kleefstra Syndrome Foundation Questions
Idefine-The Kleefstra Syndrome Foundation's website is idefine.org
Idefine-The Kleefstra Syndrome Foundation's LinkedIn profile is https://www.linkedin.com/company/idefine501c3
Idefine-The Kleefstra Syndrome Foundation has
9 employees.
View email and phone details for 9
employees at Idefine-The Kleefstra Syndrome Foundation.
Idefine-The Kleefstra Syndrome Foundation's industry is
Non-profit Organization Management
Idefine-The Kleefstra Syndrome Foundation's top competitors are
Hopewell Global Health Initiative,
Idefine Europe Foundation (Kleefstra Syndrome),
Play In Peoria,
Next Summit,
Honeycombs Industries,
Asociación Kleefstra España,
Kleefstra Syndrome France,
Wilson Language Training,
Homeopathic Services,
Kleefstra Syndrome Uk.
Idefine-The Kleefstra Syndrome Foundation's categories are Non-profit Organization Management
Idefine-The Kleefstra Syndrome Foundation's founding year is 2020
